Specific Activity of α1Proteinase Inhibitor and α2Macroglobulin in Human Serum: Application to Insulin-Dependent Diabetes Mellitus
- 31 December 1998
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 89 (3) , 247-259
- https://doi.org/10.1006/clin.1998.4605
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Proteolysis of the Human Platelet and Endothelial Cell Thrombin Receptor by Neutrophil-derived Cathepsin GPublished by Elsevier ,1995
- Interleukin‐8 processing by neutrophil elastase, cathepsin G and proteinase‐3FEBS Letters, 1994
- Response of blood leukocytes to thrombin receptor peptidesJournal of Leukocyte Biology, 1993
- The reference range for complexed α2-macroglobulin human plasma: Development of a new enzyme linked in immunosorbent assay (ELISA) for quantitation of complexed α2-macroglobulinScandinavian Journal of Clinical and Laboratory Investigation, 1993
- Use of a Highly Purified α1-Antitrypsin Standard to Establish Ranges for the Common Normal and Deficient α1-Antitrypsin PhenotypesChest, 1991
- Human leukocyte cathepsin G and elastase specifically suppress thrombin- induced prostacyclin production in human endothelial cellsBlood, 1989
- The role of inter-α-trypsin inhibitor and other proteinase inhibitors in the plasma clearance of neutrophil elastase and plasminArchives of Biochemistry and Biophysics, 1987
- THE PHENOMENON OF THE ACUTE PHASE RESPONSE*Annals of the New York Academy of Sciences, 1982
- Interaction between α1 antitrypsin and lymphocyte surface proteases: immunoregulatory effectsInflammation Research, 1981
- α1-Antitrypsin is an effector of immunological stasisNature, 1978